Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AE
- Chemical substanceJ05AE05Amprenavir
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 3 registrations
Brazil
Anvisa · 2 registrations
United States
FDA · 2 registrations
European Union
At a glance
- ATC code
- J05AE05
- ATC group
- Anti-infectives for systemic use
- Registers
- 4
- Registrations
- 8
- With their own page
- 2
- Companies
- 5
All medicines with Amprenavir
Human medicines from every register that match Amprenavir by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Agenerase | United States | 15MG/ML | solution | Not marketed | Glaxosmithkline |
| Agenerase | United States | 150MG, 50MG | capsule | Not marketed | Glaxosmithkline |
| Agenerase | European Union | Withdrawn | Glaxo Group Ltd. | ||
| Agenerase | Brazil | Cancelled | Glaxosmithkline Brasil Ltda | ||
| Agenerase | Canada | 15 MG / ML | Liquid | Cancelled | Glaxosmithkline INC |
| Agenerase | Brazil | Cancelled | Glaxo Wellcome S/A | ||
| Agenerase | Canada | 150 MG | Capsule | Cancelled | Glaxosmithkline INC |
| Agenerase | Canada | 50 MG | Capsule | Cancelled | Glaxosmithkline INC |